Concepedia

Author

Maha Elkordy

Duke Medical Center

Also Known As

M Elkordy, M. Elkordy, M.A. Elkordy, Maha A. Elkordy, Maha Elkordy

14

Publications

305

Citations

9

H-Index

18

Concepts

All Affiliations

Duke Medical CenterDuke UniversityDuke University Hospital
ME

About

Maha Elkordy is an author at Duke Medical Center specializing in medicine, hematology, and cell transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

84

2

Health Sciences

2

2

53

3

Immunology

2

2

45

4

Marrow Transplantation

2

2

40

5

Cellular Therapies

1

1

16

Maha Elkordy

×

9

Publications

288

Citations

9

H-Index

YearCitations

Coronavirus Pneumonia Following Autologous Bone Marrow Transplantation for Breast Cancer

Rodney J. Folz, Maha Elkordy

CHEST Journal

1999

68

Prognostic and Predictive Factors for Patients With Metastatic Breast Cancer Undergoing Aggressive Induction Therapy Followed by High-Dose Chemotherapy With Autologous Stem-Cell Support

David A. Rizzieri, James J. Vredenburgh, Roy B. Jones,

Journal of Clinical Oncology

1999

60

A randomized trial of recombinant human interleukin-11 following autologous bone marrow transplantation with peripheral blood progenitor cell support in patients with breast cancer

James J. Vredenburgh, Atif Hussein, David C. Fisher,

Biology of Blood and Marrow Transplantation

1998

39

A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies

William P. Petros, Maureen Ross, James J. Vredenburgh,

Cancer Chemotherapy and Pharmacology

1996

29

Thrombotic microangiopathy as a complication of high-dose chemotherapy for breast cancer.

D Fisher, Gary B. Sherrill, A Hussein,

PubMed

1996

26

Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver

D Fisher, JJ Vredenburgh, WP Petros,

Bone Marrow Transplantation

1998

24

A phase I trial of recombinant human interleukin-1β(OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation

Maha Elkordy, M. Crump, JJ Vredenburgh,

Bone Marrow Transplantation

1997

16

Results of a Phase II Study of Weekly Paclitaxel Plus Carboplatin in Advanced Carcinoma of Unknown Primary Origin: A Reasonable Regimen for the Community-Based Clinic?

William R. Berry, Maha Elkordy, Mark Allen O’Rourke,

Cancer Investigation

2007

15

Ocular toxicity following high dose chemotherapy and autologous transplant.

P. Rubin, Christine Hulette, Joseph A. Khawly,

PubMed

1996

11

Page 1